Bone morphogenetic protein type I receptor antagonists decrease growth and induce cell death of lung cancer cell lines.
about
A Survey of Strategies to Modulate the Bone Morphogenetic Protein Signaling Pathway: Current and Future PerspectivesDMH1, a small molecule inhibitor of BMP type i receptors, suppresses growth and invasion of lung cancerOptimal effector functions in human natural killer cells rely upon autocrine bone morphogenetic protein signalingActivation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinoma patients with EGFR mutations.Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death.Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growthDeletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis.Inhibition of BMP signaling suppresses metastasis in mammary cancerGenome-wide CpG island methylation and intergenic demethylation propensities vary among different tumor sites.Anti-Müllerian Hormone Signaling Regulates Epithelial Plasticity and Chemoresistance in Lung Cancer.Regulation of cellular iron metabolism and its implications in lung cancer progression.Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestinBMP2/BMPR1A is linked to tumour progression in dedifferentiated liposarcomas.Differential expression of bone morphogenetic protein 5 in human lung squamous cell carcinoma and adenocarcinoma.P53 deficiency-induced Smad1 upregulation suppresses tumorigenesis and causes chemoresistance in colorectal cancers.p73 is required for appropriate BMP-induced mesenchymal-to-epithelial transition during somatic cell reprogramming.Differential cellular responses induced by dorsomorphin and LDN-193189 in chemotherapy-sensitive and chemotherapy-resistant human epithelial ovarian cancer cells.
P2860
Q26739015-28DFF55F-49F5-42FC-A1E4-8A82CF2F6798Q28511586-A91F7587-0549-411E-8053-75B3B4F8C1CDQ34202453-ACF28BFC-2D35-4CF7-B100-C2EA32A94C63Q35961430-16F8FB88-451F-44BE-9AAF-0FE525A03170Q35980393-DF3008AE-B8E1-46B7-8F30-5C2AE75B5D6EQ36011433-8381BE0E-E638-484E-A15A-A58B4D8B837AQ36356105-482DCD4D-A737-4E19-8FB3-BDCBE19A4193Q36398681-8CEE35DE-6063-4075-B948-CDFD1375BDF2Q36588877-A08DB274-CA24-4A64-A9C0-97A6593E6167Q37116060-D5BC3EEE-FA9A-43E5-9E22-429AD3995289Q38214914-9697B89C-D4B1-4D69-AB91-1B940B1DD8DAQ38928611-437A49A0-7BBE-44B3-8093-05D0429F0D9CQ39070550-C1417F69-4ED2-4B4F-B0BC-16141E36391AQ40504792-FF6F87FF-57C5-4043-97C9-74BBA6D16F80Q41213157-4646E23E-8CFE-4BB5-BC90-31B1B71D218CQ41253276-CB6C2E9C-E911-43DB-B294-AD9AEB4779AAQ42261454-3784F40F-190D-4779-8384-64AB2C1D8248Q46837899-6CD5B877-EC71-4CF1-8E11-6F59FFC388FD
P2860
Bone morphogenetic protein type I receptor antagonists decrease growth and induce cell death of lung cancer cell lines.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Bone morphogenetic protein typ ...... ath of lung cancer cell lines.
@en
Bone morphogenetic protein typ ...... ath of lung cancer cell lines.
@nl
type
label
Bone morphogenetic protein typ ...... ath of lung cancer cell lines.
@en
Bone morphogenetic protein typ ...... ath of lung cancer cell lines.
@nl
prefLabel
Bone morphogenetic protein typ ...... ath of lung cancer cell lines.
@en
Bone morphogenetic protein typ ...... ath of lung cancer cell lines.
@nl
P2093
P2860
P1433
P1476
Bone morphogenetic protein typ ...... ath of lung cancer cell lines.
@en
P2093
Charles C Hong
Elaine Langenfeld
Gandhi Lanke
John Langenfeld
P2860
P304
P356
10.1371/JOURNAL.PONE.0061256
P407
P577
2013-04-12T00:00:00Z